The genesis of atherosclerosis and risk factors: A review

Angiology

Volumn 52, Issue 2, 2001, Pages 89-98

  Tegos, T J ^a   Kalodiki, E ^a   Sabetai, M M ^a   Nicolaides, A N ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; LIPID;

AGE; ALCOHOL CONSUMPTION; ARTERY WALL; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEMODYNAMICS; HEMOSTASIS; HOMOCYSTINURIA; HUMAN; HYPERTENSION; IMMOBILIZATION; OBESITY; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PROGERIA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STROKE; TANGIER DISEASE; WERNER SYNDROME;

EID: 0035116632     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970105200201     Document Type: Review

References (108)

1. Increased stroke incidence in Lund-Orup, Sweden, between 1983 to 1985 and 1993 to 1995
2. Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials
3. The epidemiology of peripheral arterial disease: Importance of identifying the population at risk
4. Pathology of atherosclerosis
5. Atherosclerosis: What is it and why does it occur?
6. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis
7. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis
8. Fatty streaks in the coronary arteries and aorta
9. Relationship between low-density lipoprotein in aortic intima and serum-lipid levels
10. Apolipoprotein B accumulation and development of foam cell lesions in coronary arteries of hypercholesterolemic swine
11. Transport, interactions and retention of plasma proteins in the intima: The barrier function of the internal elastic lamina
12. Plasma protein insudation as an index of early coronary atherogenesis
13. Transfer of lipoprotein from plasma to the cell population of the normal and atherosclerotic arterial tissue
14. Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells
15. Pulsatile flow and atherosclerosis in human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress
16. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries
17. Thrombus as a factor in the pathogenesis of coronary atherosclerosis
18. Atherosclerotic metamorphosis of autologous pulmonary thromboemboli in the rabbit
19. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi
20. Carbohydrate-protein macromolecules and arterial wall integrity - A role in atherogenesis
21. Changes in metabolism of connective tissue associated with aging and arterio- or atherosclerosis
22. The pathogenesis of atherosclerosis (first of two parts)
23. The pathogenesis of atherosclerosis (second of two parts)
24. The pathogenesis of atherosclerosis - An update
25. Clinical-pathological correlation of coronary disease progression and regression
26. The response to injury hypothesis of early atherogenesis
27. Mechanisms in intimal monocyte-macrophage recruitment
28. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions
29. Endothelial cell proliferation and monocyte adhesion to atherosclerotic lesions of white carneau pigeons
30. Modification of human serum low density lipoprotein by oxidation - Characterisation and pathophysiological implications
31. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
32. Development of the smooth muscle foam cell: Uptake of macrophage lipid inclusions
33. Culture endothelial cells produce a platelet-derived growth factor-like protein
34. Smooth muscles cells and the pathogenesis of the lesions of atherosclerosis
35. Sis (Platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery
36. Regulation of smooth muscle cell growth in injured artery
37. Smooth muscle phenotypic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis
38. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions
39. Immune mechanisms in atherosclerosis
40. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
41. Interferon gamma inhibits both proliferation and expression of differentiation - Specific alpha-smooth muscle actin in arterial smooth muscle cells
42. Detection of activated T lymphocytes in the human atherosclerotic plaque
43. Atherosclerotic calcification: Relation to developmental osteogenesis
44. Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction
45. Role of thrombosis in atherosclerosis and its complications
46. Compensatory enlargement of human atherosclerotic coronary arteries
47. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death
48. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolisation culminating in total vascular occlusion
49. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina
50. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques
51. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques
52. Why do plaques rupture?
53. Atherosclerotic plaque rupture and thrombosis
54. Coronary thrombosis: Pathogenesis and clinical manifestations
55. A critical review of the relationship between impaired fibrinolysis and myocardial infarction
56. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
57. Diabetes and cardiovascular risk factors: The Framingham study
58. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
59. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
60. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
61. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis
62. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
63. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study
64. Incidence of coronary heart disease and lipoprotein cholesterol levels
65. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women
66. Smoking and death rates - Report on forty-four months of follow-up of 187,783 men
67. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes
68. Cigarette smoking and plasma high-density lipoprotein cholesterol: The Lipid Research Clinics Program Prevalence Study
69. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease
70. Perspectives on systolic hypertension. The Framingham study
71. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data
72. Mortality in type 2 diabetes
73. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study
74. Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial
75. A meta-analysis of physical activity in the prevention of coronary heart disease
76. Risk factors (AHA conference proceedings)
77. Alcohol and other discriminants between cases of sudden death and myocardial infarction
78. Drinking habits and cardiovascular disease: The Framingham Study
79. Moderate alcohol consumption and coronary artery disease. A review
80. A prospective study of moderate alcohol drinking and risk of diabetes in women
81. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: Results from the Lipid Research Clinics Follow-up Study
82. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction
83. The influence of obesity on health (second of two parts)
84. The importance of obesity in the development of coronary risk factors and disease: The epidemiologic evidence
85. Secular trends in body mass in the United States, 1960-1980
86. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project
87. Obesity in relation to morbidity and mortality from cardiovascular disease
88. Body weight and risk of myocardial infarction and death in the adult population of eastern Finland
89. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
90. Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease
91. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies
92. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men
93. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study
94. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
95. Platelet hyperreactivity and prognosis in survivors of myocardial infarction
96. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men
97. 6, and folate: Metabolic interrelationships and clinical significance
98. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
99. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease)
100. The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature
101. Werner's syndrome: A review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations
102. Carotid artery occlusive disease following external cervical irradiation
103. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
104. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
105. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms
106. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction